We’ve added HubSpot to our list of digital workflow integration options available from within our HRA Management Portal.
Read MoreUpdate:
New 90-Day HRA Performance Reviews with Clients
Our new HRA Performance Reviews are 90-day check-ins to improve implementation and performance to help you achieve your goals.
Read MoreHRA Tip:
Promote COVID Vaccinations via HRA Results to All or Only At-Risk Patients
Use the custom Calls-to-Action (CTAs) and Follow-Up Emails features of our health risk assessments (HRAs) to promote COVID vaccinations.
Read MoreTips & Support:
Outdated HRA Links? A 2-Step Solution to Update
Are you currently using v2 health assessments? Would you like to upgrade to the latest v3 platform but you’re not sure if all remaining v2 links were removed from your site and campaigns? Good news, Medicom Health is here to help by automatically redirecting old URLs!
Read MoreHRA Upgrade:
Marketo Integration: New HRA Digital Workflow Feature
We’ve added Marketo to our list of digital workflow integration options available from within our HRA Management Portal.
Read MoreUpcoming Trade Show:
SHSMD 20/20 Connections Bytes
—
The Society for Health Care Strategy & Market Development (SHSMD) 20/20 Connections Bytes virtual conference is October 27 & 28.
Read MoreNew HRA:
2020 Prostate Cancer HRA Upgrade
We’ve recently upgraded our Prostate Cancer risk assessment. This short assessment helps men learn the factors that increase their prostate cancer risk.
Read MoreHRA Upgrade:
Formstack Integration: New HRA Digital Workflow Feature
We’ve added Formstack to our list of digital workflow integration options available from within our HRA Management Portal.
Read MoreNews:
One Year Since Medicom Health Achieved HITRUST® Certification
Medicom Health has earned HITRUST certification for our health risk assessment (HRA) platform for health system marketers.
Read MoreUpcoming Trade Show:
Visit Our Virtual Booth at HMPS 2020
—
We will be exhibiting at The 25th Annual Healthcare Marketing & Physician Strategies Summit (HMPS) virtually. We’d love to chat!
Read More
Thank you for your interest.